https://www.capybararesearch.com/post/knightscope-from-a-robocop-inspired-fairytale-to-a-dilution-dilemma-a-battle-for-survival Disclosure: We hold a short position in shares of $KSCP and firmly believe that its equity

KSCP

Oppenheimer Maintains Outperform on Akoustis Technologies, Lowers Price Target to $7

By Benzinga Newsdesk

November 15, 7:33 AM

Oppenheimer analyst Rick Schafer maintains Akoustis Technologies (NASDAQ:AKTS) with a Outperform and lowers the price target from $8 to $7.

AKTS

Bitcoin, Ethereum, Dogecoin See Large Liquidations Amid FTX Scare

By Mehab Qureshi

November 8, 1:51 AM

As Sam Bankman-Fried's FTX witnesses an intensive selloff in its native token, FTT (CRYPTO:

$BUSD

Credit Suisse Upgrades Phillips Edison to Outperform

Related Posts

Jefferies Downgrades Aveanna Healthcare Hldgs to Hold, Lowers Price Target to $2.5

Watching Knightscope; Capybara Research Releases Short Report On Co Titled ‘Knightscope – From A RoboCop Inspired Fairytale To An Inevitable Dilution Dilemma $0.5 Target’

Oppenheimer Maintains Outperform on Akoustis Technologies, Lowers Price Target to $7

Bitcoin, Ethereum, Dogecoin See Large Liquidations Amid FTX Scare